SCYNEXIS
$7.739876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-0.51%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell SCYNEXIS and other stocks, options, and ETFs commission-free!
About SCYX
SCYNEXIS, Inc. Common Stock, also called SCYNEXIS, is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections.
CEO
Marco Taglietti
Employees
38
Headquarters
Jersey City, New Jersey
Founded
1999
Market Cap
168.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
247.32K
High Today
$7.88
Low Today
$7.65
Open Price
$7.88
Volume
299.78K
52 Week High
$10.40
52 Week Low
$4.20
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
SCYX Earnings
-$3.78
-$2.52
-$1.26
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market